MktsMarkets

Encompass Health Corporation
NYSE: EHCKey statistics
EHC News
Stories mentioning EHC from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,586,600 | 1,544,600 | 1,477,500 | 1,457,700 | 1,455,400 | 1,405,000 | 1,351,000 | 1,301,200 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | ||||||||
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 18,700 | 3,700 | 5,900 | 6,700 | 2,500 | 2,100 | 9,300 | 3,300 |
| Pretax Income | 288,700 | 257,700 | 219,900 | 236,800 | 238,600 | 201,400 | 183,800 | 186,000 |
| Tax Provision | 56,400 | 55,400 | 44,900 | 51,000 | 41,600 | 37,600 | 36,000 | 38,300 |
| Net Income (Loss) | 194,500 | 146,100 | 126,500 | 142,100 | 151,500 | 120,900 | 108,200 | 114,100 |
| Earnings Per Share (Basic) | 1.96 | 1.45 | 1.26 | 1.41 | 1.50 | 1.21 | 1.08 | 1.13 |
| Earnings Per Share (Diluted) | 1.93 | 1.43 | 1.24 | 1.39 | 1.48 | 1.18 | 1.06 | 1.12 |
| Weighted Average Shares Outstanding (Basic) | 99,200 | 100,500 | 100,500 | 100,600 | 100,500 | 99,900 | 99,900 | 99,900 |
| Weighted Average Shares Outstanding (Diluted) | 100,600 | 102,200 | 102,300 | 102,300 | 102,100 | 102,200 | 102,100 | 102,000 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About EHC
Encompass Health Corporation (NYSE: EHC) is a stock listed on the New York Stock Exchange under the ticker symbol EHC. It last traded at $135.90 (Oct 30, 2026, 4:00 PM ET), up 3.4% on the day. That gives Encompass Health a market capitalisation of $13.4B and a price-to-earnings ratio of 21.6.
Over the past 52 weeks EHC has traded between $92.77 and $133.75.
Revenue for the quarter ended Mar 31, 2026 was $1.6B; net income $194.5M. Revenue was up 9.0% from $1.5B in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $1.6B | $194.5M | 12.3% |
| Dec 31, 2025 | $1.5B | $146.1M | 9.5% |
| Sep 30, 2025 | $1.5B | $126.5M | 8.6% |
| Jun 30, 2025 | $1.5B | $142.1M | 9.7% |
From Encompass Health’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…